Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Edner

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
JAMA|November 29, 2012
Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fractionLars H Lund, Lina Benson, Ulf Dahlström, et al.
European Journal of Heart Failure|January 28, 2014
Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registryUlrik Sartipy, Ulf Dahlström, Magnus Edner, et al.
European Heart Journal|June 13, 2015
Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort studyMagnus Edner, Lina Benson, Ulf Dahlström, et al.
Journal of Women'S Health (2002)|March 15, 2008
Sex differences in systolic heart failure in the elderly: the prognostic importance of left ventricular mass in womenMarit Mejhert, Thomas Kahan, Magnus Edner, et al.
Scandinavian Cardiovascular Journal : SCJ|November 18, 2008
Congestive heart failure with and without atrial fibrillation - different patient populations?David Waldenhjort, Märit Mejhert, Magnus Edner, et al.
European Journal of Heart Failure|February 13, 2016
Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012Tonje Thorvaldsen, Lina Benson, Ulf Dahlström, et al.
American Journal of Hypertension|September 1, 2006
Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA)Richard Müller-Brunotte, Thomas Kahan, Karin Malmqvist, et al.
Circulation. Heart Failure|January 11, 2015
Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure RegistryUrban Alehagen, Lina Benson, Magnus Edner, et al.
JAMA|November 17, 2014
Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fractionLars H Lund, Lina Benson, Ulf Dahlström, et al.
Circulation. Heart Failure|August 6, 2015
Association Between Use of Statins and Mortality in Patients With Heart Failure and Ejection Fraction of ≥50Urban Alehagen, Lina Benson, Magnus Edner, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
JAMA|November 29, 2012
Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fractionLars H Lund, Lina Benson, Ulf Dahlström, et al.
European Journal of Heart Failure|January 28, 2014
Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51,043 patients from the Swedish heart failure registryUlrik Sartipy, Ulf Dahlström, Magnus Edner, et al.
European Heart Journal|June 13, 2015
Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort studyMagnus Edner, Lina Benson, Ulf Dahlström, et al.
Journal of Women'S Health (2002)|March 15, 2008
Sex differences in systolic heart failure in the elderly: the prognostic importance of left ventricular mass in womenMarit Mejhert, Thomas Kahan, Magnus Edner, et al.
Scandinavian Cardiovascular Journal : SCJ|November 18, 2008
Congestive heart failure with and without atrial fibrillation - different patient populations?David Waldenhjort, Märit Mejhert, Magnus Edner, et al.
European Journal of Heart Failure|February 13, 2016
Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012Tonje Thorvaldsen, Lina Benson, Ulf Dahlström, et al.
American Journal of Hypertension|September 1, 2006
Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA)Richard Müller-Brunotte, Thomas Kahan, Karin Malmqvist, et al.
Circulation. Heart Failure|January 11, 2015
Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure RegistryUrban Alehagen, Lina Benson, Magnus Edner, et al.
JAMA|November 17, 2014
Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fractionLars H Lund, Lina Benson, Ulf Dahlström, et al.
Circulation. Heart Failure|August 6, 2015
Association Between Use of Statins and Mortality in Patients With Heart Failure and Ejection Fraction of ≥50Urban Alehagen, Lina Benson, Magnus Edner, et al.
Pageof 6